Zhen Huan (Kenny) Hu
About Zhen Huan (Kenny) Hu
Zhen Huan (Kenny) Hu is an Associate Director of Medical Affairs specializing in Real World Evidence at Kite Pharma, with over ten years of experience in statistical modeling and survival analysis, particularly in hematologic malignancies.
Current Role at Kite Pharma
Zhen Huan (Kenny) Hu serves as the Associate Director of Medical Affairs – Real World Evidence at Kite Pharma. He has held this position since 2022, working remotely. In this role, he focuses on conducting real-world evidence studies, particularly in the area of hematologic malignancies. His expertise in this field contributes to the development and evaluation of therapies, enhancing the understanding of treatment outcomes in real-world settings.
Previous Experience at Medical College of Wisconsin
Prior to his current role, Zhen Huan (Kenny) Hu worked at the Medical College of Wisconsin for seven years, from 2011 to 2018, as a Biostatistician. He later advanced to the position of Senior Biostatistician – Cellular Therapy Lead from 2018 to 2021. In these roles, he was involved in statistical modeling and analysis, contributing to research in cellular therapies and other medical studies.
Education and Expertise
Zhen Huan (Kenny) Hu earned a Master of Public Health (MPH) in Epidemiology from the University of Minnesota-Twin Cities, where he studied from 2008 to 2010. He also holds a Bachelor of Science (BS) in Biological Science from Fudan University, completed from 2004 to 2008. His educational background supports his extensive experience in statistical modeling and survival analysis, with a focus on real-world evidence and post-marketing CAR T-cell research.
Experience in Public Health
Zhen Huan (Kenny) Hu began his career in public health as an Epidemiologist at the Minnesota Department of Health, where he worked for three months in 2010. This role provided him with foundational experience in epidemiological research and data analysis, which he later applied in his biostatistics and medical affairs roles.
Specialization in Hematologic Malignancies
Zhen Huan (Kenny) Hu specializes in conducting real-world evidence studies with a specific focus on hematologic malignancies. He has over ten years of experience in statistical modeling and survival analysis, along with more than five years dedicated to post-marketing CAR T-cell research. His work aims to improve understanding of treatment efficacy and patient outcomes in this critical area of oncology.